PT938329E - Composicao de tlp imunogenica - Google Patents

Composicao de tlp imunogenica

Info

Publication number
PT938329E
PT938329E PT97945086T PT97945086T PT938329E PT 938329 E PT938329 E PT 938329E PT 97945086 T PT97945086 T PT 97945086T PT 97945086 T PT97945086 T PT 97945086T PT 938329 E PT938329 E PT 938329E
Authority
PT
Portugal
Prior art keywords
seq
immunogenic
tlp
composition
tlp composition
Prior art date
Application number
PT97945086T
Other languages
English (en)
Inventor
Giulio Tarro
Original Assignee
Unihart Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unihart Corp filed Critical Unihart Corp
Publication of PT938329E publication Critical patent/PT938329E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/55Lung
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/46Cellular immunotherapy
    • A61K39/461Cellular immunotherapy characterised by the cell type used
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/46Cellular immunotherapy
    • A61K39/464Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643Vertebrate antigens
    • A61K39/4644Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • A61K2039/86Lung
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/80Vaccine for a specifically defined cancer
    • A61K2039/892Reproductive system [uterus, ovaries, cervix, testes]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PT97945086T 1996-10-09 1997-10-09 Composicao de tlp imunogenica PT938329E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000687A IT1294967B1 (it) 1996-10-09 1996-10-09 Composizione immunogenica da tlp

Publications (1)

Publication Number Publication Date
PT938329E true PT938329E (pt) 2002-10-31

Family

ID=11404462

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97945086T PT938329E (pt) 1996-10-09 1997-10-09 Composicao de tlp imunogenica

Country Status (17)

Country Link
US (2) US20020031531A1 (pt)
EP (1) EP0938329B1 (pt)
JP (1) JP2001508764A (pt)
KR (1) KR20000048995A (pt)
CN (1) CN1239431A (pt)
AT (1) ATE218064T1 (pt)
AU (1) AU725218B2 (pt)
CA (1) CA2267905A1 (pt)
DE (2) DE938329T1 (pt)
DK (1) DK0938329T3 (pt)
ES (1) ES2138574T3 (pt)
IL (1) IL129368A0 (pt)
IT (1) IT1294967B1 (pt)
NO (1) NO991653L (pt)
PT (1) PT938329E (pt)
RU (1) RU2192274C2 (pt)
WO (1) WO1998015282A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1317853B1 (it) * 2000-02-25 2003-07-15 Unihart Corp Peptidi tlp e sequenze di dna che li codificano.
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
ES2394969T3 (es) 2004-12-30 2013-02-07 Vito Michele Fazio Péptidos inmunógenos antitumorales y vacuna que los contiene
EP2252690A2 (en) * 2007-12-21 2010-11-24 Coda Therapeutics, Inc. Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
ITRM20100256A1 (it) * 2010-05-19 2011-11-20 Farmafin Spa Un nuovo biomarcatore per la diagnosi precoce e l'immunoterapia del cancro
EP3167898A1 (en) 2015-11-11 2017-05-17 IEO - Istituto Europeo di Oncologia Srl Method for obtaining tumor peptides and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206250B (it) * 1987-02-18 1989-04-14 Ist Farmacoterapico It Spa Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla-
IT1262954B (it) * 1992-07-03 1996-07-23 Ist Farmacoterapico It Spa Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.

Also Published As

Publication number Publication date
CA2267905A1 (en) 1998-04-16
AU725218B2 (en) 2000-10-05
US20020031531A1 (en) 2002-03-14
DE69712907D1 (de) 2002-07-04
IL129368A0 (en) 2000-02-17
ATE218064T1 (de) 2002-06-15
EP0938329A1 (en) 1999-09-01
NO991653D0 (no) 1999-04-08
IT1294967B1 (it) 1999-04-23
AU4637697A (en) 1998-05-05
RU2192274C2 (ru) 2002-11-10
WO1998015282A1 (en) 1998-04-16
DK0938329T3 (da) 2002-09-09
DE69712907T2 (de) 2002-12-12
EP0938329B1 (en) 2002-05-29
US20040022870A1 (en) 2004-02-05
DE938329T1 (de) 2000-04-06
KR20000048995A (ko) 2000-07-25
JP2001508764A (ja) 2001-07-03
ES2138574T3 (es) 2002-11-01
NO991653L (no) 1999-06-08
CN1239431A (zh) 1999-12-22
ES2138574T1 (es) 2000-01-16
ITRM960687A1 (it) 1998-04-09

Similar Documents

Publication Publication Date Title
EP2258383A3 (en) Antigenic peptides derived from telomerase
BG102714A (en) Pharmaceutical composition for immunomodulation based on peptides and adjuvants
HK1043475A1 (en) Compositions and methods for treating infections using analogues of indolicidin
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
EP1918300A3 (en) Peptide-based immunization therapy for treatment of atherosclerosis
DE69922822D1 (de) Rekombinante haarbehandlungsmittel
EP1484339A3 (en) Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
NZ279963A (en) Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
AUPP589598A0 (en) Novel peptides
CA2234263A1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
EP1071443A4 (en) ISOLATED PEPTIDES CORRESPOND THE NY-ESO-1 AMINO ACID SEQUENCES AND BIND TO MHC CLASS I AND MHC CLASS II MOLECULES AND THEIR USE
DE69420145D1 (de) Behandlung präkanzeröser läsionen durch muramylpeptide
PT938329E (pt) Composicao de tlp imunogenica
AU1239997A (en) Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes
EA200100395A1 (ru) Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием
AU3711597A (en) A novel galanin receptor
PT782630E (pt) Gene da doenca poliquistica do rim
UA83989C2 (ru) Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
EP1174439A3 (en) Compositions and methods for treating infections using analogues of indolicidin
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
NO20011263D0 (no) Moraxella Catarrhalis BASBO34-polypeptider og anvendelser derav
SE9604439D0 (sv) New receptor